This is the second installment in our Sort of Sober series, in which we look at legal mind- and body-altering substances.

Marketed as an energy- and mood-boosting miracle herb, kratom has become a lifeline for some — and a dangerous trap for others.
An estimated 1.7 million Americans ages 12 and up used the substance in 2021, per the Substance Abuse and Mental Health Services Administration’s annual National Survey on Drug Use and Health, about .6% of the population at that time.
That figure could grow: Available statewide at vape shops, gas stations and online, kratom remains almost wholly unregulated by the government (the Food and Drug Administration has outlined its many concerns) and is a mystery to many.
What is kratom?
Kratom — pronounced KRAY-tum — is a tropical tree in the coffee family native to Southeast Asia, according to the Drug Enforcement Administration. Consumption of its leaves produces stimulant effects in low doses and sedative effects in high doses, and can lead to psychotic symptoms as well as psychological and physiological dependence.
Kratom’s leaves — which contain two major psychoactive ingredients, mitragynine and 7-hydroxymitragynine — are crushed and then smoked, brewed with tea or placed into gel capsules. Kratom has a long history of use in Southeast Asia, where it is commonly known as thang, kakuam, thom, ketum and biak.
Read More
Proponents say kratom can alleviate pain and anxiety, increase energy and even be used to help kick opioid addiction. Meanwhile, substance abuse doctors and several government agencies caution against using it, some going so far as saying kratom, in many ways, is nearly as challenging to stop using as opioids.
“I’ve seen a half-dozen patients taking this. Two to three weeks after you’re on it, you try stopping it and you have withdrawal symptoms like an opioid,” said Mark Guy, a doctor at Allegheny Health Network's Center for Recovery Medicine who specializes in addiction medicine and substance use disorder.
One of those patients, Bill W. of the North Hills, whose surname is being withheld to protect his privacy, shared an account of how he started taking kratom more than five years ago for knee pain and has been struggling for the past year to stop.
“I was curious about it. The store employee basically said it gives you some energy and helps with pain. And what I found was that when I started kratom, it was a miracle drug for me.” Not only did it take away his knee pain, but kratom “almost completely eliminated my anxiety and it gave me a ton of energy.”
Bill said he used kratom for about three years, slowly needing to increase the amount he was ingesting. “What ended up happening was that I couldn’t skip a day of it and then after time, it had the opposite effect on me. I mean the pain was still alleviated, but my anxiety was through the roof.”
Bill, who is 13 years sober from an alcohol addiction, recounted one dinner where he and his wife were sharing a meal at an Indian restaurant. He had taken kratom beforehand and “we were sharing food and she got really scared because I was shaking so bad.” He said kratom caused “shaking or convulsing uncontrollably” a couple of times.
“So after way too long, to be honest, I said to myself, ‘I have to get off of this stuff.’ Tapering down was not working for me and my biggest complaint was restless leg syndrome. I couldn’t sleep without this stuff. At midnight or 1 a.m. I would go out to my car and take a big heaping spoonful of it just so I could go to bed.”
Bill finally sought treatment options with Guy, who prescribed suboxone, the same drug that is used to help those trying to kick heroin. Six months into treatment, Bill says the restless leg syndrome lingers. He doesn’t know when it’ll ever stop.
“Shops have whole walls dedicated to this stuff and I always see people buying it. It’s very addictive. It’s absolutely addictive. …You take a shot of that and you’re happy to go to work. Until you need more and more and maybe realize you can’t do without it. You see it next to the cash register, you think of it like a 5-Hour Energy [shot]. … It’s going to sneak up and bite a lot of people in the ass.”
C. M. "Mac" Haddow, senior fellow on public policy at the American Kratom Association, based in Gainesville, Va., says Bill’s experience is far from common.
“It doesn't control pain even at high doses like opioids do, but it lets people avoid the risks of an opioid and it lets them manage their lives,” said Haddow, a longtime Capitol Hill lobbyist who served as the campaign manager for Orrin Hatch's first senate campaign in 1976 and later served as chief of staff for former Health and Human Services Secretary Margaret Heckler; he served four months in federal prison in the late 1980s on conflict of interest charges stemming from his time as chief of staff. “They can actually function. And that's what I hear from hundreds and hundreds and hundreds of consumers as I've gone around the country.” Haddow cited hearings at which consumers have told lawmakers, “’This has saved my life. It's allowed me back into society, to function, to be a parent, to be a spouse, to be a worker,’ where before they were just smacked up on the opioids.”

Lack of solid research
Studies on kratom to date are limited, both in scope and number, with mixed findings that highlight both its potential therapeutic benefits and significant risks, underscoring the need for more comprehensive, high-quality research to fully understand its effects on health and safety.
Currently there are very few double-blind, placebo-controlled studies on kratom. Most research relies heavily on voluntary, user-reported information. These self-reported studies often include surveys about kratom use, motivations, perceived benefits and adverse effects, but they lack the rigorous controls of clinical trials.
“The vagaries around the legal status of kratom (and its active ingredient mitragynine) contribute to the hesitancy,” Kent Vrana, emeritus chair of pharmacology at Penn State’s College of Medicine and director of PSU’s Medical Marijuana Academic Clinical Research Center, said in an email.
“The DEA has labeled it as a ‘drug of concern,’ but have not added it to the list of abused controlled substances (e.g., cocaine, heroin, LSD). On the other hand, six states have outlawed its use. So, as a researcher, I would be very careful about deliberately giving it to humans because there are no documented benefits and it carries risk.”
Brayden Kameg, assistant professor of nursing in the University of Pittsburgh Nursing School's health and community systems department, said she has worked with multiple patients who used kratom then suffered withdrawal symptoms, ones “that looked just like opioid withdrawal.” In fact, the condition is treated the same way as opioid withdrawal, she said.
“About 10 years ago there was a big push among patients and some advocates to try kratom to get off heroin or fentanyl, but they underappreciated the addictive potential of kratom,” Kameg said.
Guy echoed many of Kameg’s observations: “There’s a number of patients that have come in and told me, ‘My knee felt so much better, I have more energy, it worked really great and it worked for two weeks, but I went off it and I have the shakes, diarrhea, and I can’t sleep. We treat it like we treat opioid dependence.”
Kratom’s 7-hydroxymitragynine is 13 times more potent than morphine, Guy said. This is backed up by several published studies.
“You would think that if you can buy it in a convenience store, then it can’t be that dangerous, and that’s simply not the case. Kids can go in and buy these things,” said Guy. And potential effects in children are even scarier, he said: Kratom could cause permanent neurological damage or trigger underlying psychiatric illnesses. “None of these substances would I consider safe,” he said.
“Because they’re everywhere and so easily available, I do find that adolescents have some false reassurance and their parents don’t understand the dangers,” Kameg said. “They think, ‘I get it the same way I get Tyloenol, Motrin or cigarettes,’ so they tend to think it's safer than it really is.”

Consumer protection
Haddow agrees that kratom should be kept out of the hands of children, and that the government should step in to protect consumers — but not by banning it or scheduling it as a controlled substance. Instead, he urges state legislators to adopt the Kratom Consumer Protection Act, which calls for enforcing accurate labeling, restricting purchase by age and requiring Good Manufacturing Practices standards among other measures.
The Association has also lobbied extensively for the Federal Kratom Consumer Protection Act, which, in addition to similar provisions of the state legislation, also would require the FDA to hold public hearings and establish a task force to examine kratom. The act was introduced into the federal legislative process in October 2023 as a senate bill by Sen. Mike Lee, R-Utah, and co-sponsor Sen. Cory Booker, D-N.J., and as as a house bill by Rep. Mark Pocan, D-Wisconsin, and co-sponsor Rep. Jack Bergman, R-Michigan. Critics of the federal bill say the legislation may prioritize industry interests over consumer safety.
The FDA recommends limits for caffeine intake and, Haddow said, “[t]he same should apply for kratom,” with the agency taking the lead on determining a safe daily consumption level.
The National Institutes on Drug Abuse (NIDA, housed under the National Institutes of Health), Haddow said, “gets it right. They recognize that it has therapeutic benefits that can be a harm reduction tool for people that are struggling with addictions.” The NIH, however, has not come right out and endorsed kratom’s touted benefits. Instead, one could conservatively say it is remaining optimistically neutral, with reservations.
The NIH’s kratom information page states that “NIDA and the NIH HEAL (Helping to End Addiction Long-term) Initiative are supporting several studies evaluating kratom and related compounds as potential treatments for chronic pain and for opioid withdrawal and opioid use disorder.”
But the page goes on to list several areas of concern:
- Kratom products may contain harmful contaminants.
- Adverse effects range from mild to severe.
- A very small number of deaths have been linked to kratom products compared to deaths from other drugs.
- Drug interactions may influence effects.
- Long-term health and safety effects are not well understood.
- Effects on pregnancy are not well understood.
- Safety effects of intoxication are not well understood.
Pa. regulation, or lack thereof
State Rep. Jim Struzzi, R-Indiana, in 2020 introduced a bill to the state general assembly “urging the United States Food and Drug Administration to recognize this Commonwealth's concern with the safety of kratom and the current distribution and sale of kratom as a drug replacement, supplement or food and to promptly consider guidelines and protocols for the safe use of kratom.”
The action quickly drew pushback from kratom users and grassroots organizations, who told Struzzi that kratom gave them an alternative to opioids. Struzzi said the feedback he received at that time was overwhelmingly in favor of keeping kratom available to the public.
“Nobody has approached me about [regulating kratom] in years,” he said during a recent phone interview. “I was kind of torn and in the middle of all that,” so he backed off and instead decided to keep his legislative focus on harder drugs such as heroin and fentanyl. “But I think it’s still a concern — anything that is not regulated, and not much is known about the overall effects.”
In 2023, state Sen. Tracy Pennycuick, R-Montgomery County, introduced the American Kratom Association’s Kratom Consumer Protection Act to restrict sales to minors and establish basic consumer protections. The bill has since been withdrawn.
Haddow said his organization was working with Pennycuick: “She's going to refile the bill and we're going to strengthen it a little bit with more consumer protections because we've learned about some of the games that people are playing. So, we want to be more specific in how the product should be formulated and labeled.”
A Pennycuick staff member confirmed the senator is working with the American Kratom Association and that she plans to reintroduce the measure in 2025.
“We need the Consumer Protection Act in Pennsylvania because that would be an additional buffer to make sure that there is no product that is sold on the shelves in Pennsylvania that is not meeting the standards that are set forth in a state law. Because right now, it's the wild west and Pennsylvania consumers are exposed to products that should not be on the marketplace,” Haddow said.
While advocates like Haddow push for regulations to bring order to the kratom market, substance abuse experts continue to warn that the accessibility and lack of oversight pose a growing risk.
Kratom and other gas station drugs are “readily available. They’re not illegal. It’s more socially acceptable. You’re not buying them from a dealer in a back alley,” said Guy. “I don’t see anyone getting out ahead of this and closing the door on this. You poll 100 people off the street, unless they’re teenagers. … I think many people have no idea this is going on.”






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.